70.31

0.11% 0.08

After Hours: 70.31

The Cooper Companies, Inc. (COO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

The Cooper Companies, Inc. stock is traded at $70.31, with a volume of 1.47M. It is up +0.11% in the last 24 hours and up +2.15% over the past month. The Cooper Companies, Inc. operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. It also provides range of products and services focusing on women's health, including medical devices, fertility, genomics, and diagnostics and contraception for hospitals and surgical centers, obstetricians' and gynecologists' (ob/gyns) medical offices, and fertility clinics. In addition, the company offers carrier screening, preimplantation genetic screening, and preimplantation genetic diagnosis used in IVF process; IVF medical devices, systems, and equipment; and PARAGARD, a non-hormonal, copper intrauterine device for birth control. Further, The Cooper Companies, Inc. offers its products under Biofinity, clarity 1day, MyDay, and Proclear 1 Day brand name. The company markets its products through a network of field sales representatives, independent agents, and distributors. The Cooper Companies, Inc. was founded in 1980 and is headquartered in Pleasanton, California.

Previous Close:

$70.23

Open:

$70.61

24h Volume:

1.47M

Relative Volume:

0.52

Market Cap:

$13.71B

Revenue:

$4.23B

Net Income/Loss:

$235.80M

P/E Ratio:

59.38

EPS:

1.1841

Net Cash Flow:

$569.50M

1W Performance:

-1.95%

1M Performance:

+2.15%

6M Performance:

-13.51%

1Y Performance:

-4.73%

1-Day Range:

$70.20

$70.90

1-Week Range:

$69.60

$71.94

52-Week Range:

$58.89

$89.83

The Cooper Companies, Inc. Stock (COO) Company Profile

Name

The Cooper Companies, Inc.

Sector

Healthcare (1071)

Industry

Medical Instruments & Supplies (57)

Phone

925-460-3600

Address

6140 Stoneridge Mall Road, Suite 590, Pleasanton, CA

Employee

12,000

Twitter

Next Earnings Date

2026-08-26

Latest SEC Filings

COO's Discussions on Twitter

Compare COO vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COO The Cooper Companies, Inc.	70.31	13.70B	4.23B	235.80M	569.50M	1.1841
ISRG Intuitive Surgical Inc	337.50	118.96B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	156.36	42.15B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	67.91	32.78B	10.63B	819.00M	1.59B	1.6577
MDLN Medline Inc	38.75	31.82B	29.14B	1.07B	1.05B	1.1956
RMD Resmed Inc	195.27	27.83B	5.54B	1.52B	1.74B	10.37

The Cooper Companies, Inc. Stock (COO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-04-26	Downgrade	Rothschild & Co Redburn	Buy → Neutral
Feb-03-26	Reiterated	Needham	Buy
Nov-13-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-13-25	Initiated	Barclays	Overweight
Oct-01-25	Initiated	Goldman	Sell
Aug-28-25	Downgrade	Citigroup	Buy → Neutral
Jul-22-25	Upgrade	BNP Paribas Exane	Neutral → Outperform
Jun-17-25	Upgrade	Needham	Hold → Buy
May-30-25	Downgrade	JP Morgan	Overweight → Neutral
Aug-29-24	Reiterated	Piper Sandler	Overweight
Jul-16-24	Upgrade	Jefferies	Hold → Buy
Mar-19-24	Upgrade	Redburn Atlantic	Neutral → Buy
Mar-13-24	Upgrade	JP Morgan	Neutral → Overweight
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-30-23	Initiated	BofA Securities	Buy
Oct-05-23	Downgrade	Redburn Atlantic	Overweight → Neutral
May-30-23	Initiated	Morgan Stanley	Equal-Weight
Dec-22-22	Initiated	Mizuho	Buy
Nov-30-22	Upgrade	Robert W. Baird	Neutral → Outperform
Oct-12-22	Downgrade	Jefferies	Buy → Hold
Aug-29-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-17-22	Upgrade	Citigroup	Neutral → Buy
Apr-08-22	Initiated	Needham	Hold
Jan-03-22	Upgrade	Guggenheim	Neutral → Buy
Sep-03-21	Reiterated	Citigroup	Neutral
Sep-03-21	Reiterated	KeyBanc Capital Markets	Overweight
Sep-03-21	Reiterated	Oppenheimer	Perform
Sep-03-21	Reiterated	Stifel	Buy
Apr-23-21	Initiated	Redburn	Buy
Jul-06-20	Downgrade	Robert W. Baird	Outperform → Neutral
Mar-05-20	Initiated	Citigroup	Neutral
Feb-01-19	Upgrade	Stephens	Equal-Weight → Overweight
Jan-04-19	Downgrade	Goldman	Neutral → Sell
Jul-30-18	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
Apr-04-18	Initiated	Goldman	Neutral
Dec-08-17	Reiterated	Stifel	Buy
Sep-12-17	Reiterated	Stifel	Buy
Sep-01-17	Reiterated	Piper Jaffray	Overweight
Jul-21-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Jun-29-17	Initiated	Guggenheim	Neutral
Jun-02-17	Reiterated	Stifel	Buy
Dec-12-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-02-16	Reiterated	BMO Capital Markets	Outperform
Aug-31-16	Reiterated	Stifel	Buy
Jun-30-16	Reiterated	Stifel	Buy
Jun-03-16	Reiterated	Jefferies	Buy
Apr-15-16	Upgrade	Jefferies	Hold → Buy
Dec-17-15	Initiated	Goldman	Neutral
Dec-04-15	Downgrade	JP Morgan	Overweight → Neutral

View All

The Cooper Companies, Inc. Stock (COO) Latest News

Jul 24, 2026

The Cooper Companies’ Q2 2026 Earnings: What to Expect - Barchart.com

Jul 24, 2026

CooperCompanies stock trades steadily as contact lens growth supports earnings - AD HOC NEWS

Jul 24, 2026

Jul 22, 2026

CooperCompanies stock steadies as investors weigh Vision and fertility growth - AD HOC NEWS

Jul 22, 2026

CooperCompanies stock trades steadily as vision care growth supports earnings - AD HOC NEWS

Jul 22, 2026

Jul 20, 2026